Cafepharma Today

April 11 2025 - The 5 largest biopharma layoffs of Q1 2025
The 5 largest biopharma layoffs of Q1 2025
Why Amgen hired an AI head from Nike
Market volatility compounds ‘already challenging’ year for biotech IPOs
41% of drug shortages span more than 2 years
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hot Small Caps: Shire leads gainers in pharma sector
Reuters, UK
Friday, October 31, 2008 - 10:02am
tags:
Sanofi best-sellers help lift net profit in 3Q
Yahoo/AP
Friday, October 31, 2008 - 10:00am
tags:
Insurers entice doctors to prescribe generic drugs
Google/AP
Friday, October 31, 2008 - 9:59am
tags:
Pension Fund Thinks Lilly / Imclone Deal Too Cheap
Seeking Alpha
Friday, October 31, 2008 - 9:58am
tags:
Pfizer CEO Kindler Calls for More Science, Less Politics at FDA
WSJ Online
Friday, October 31, 2008 - 9:41am
tags:
Rigel's Punishment May Prove Short-Sighted
Seeking Alpha
Friday, October 31, 2008 - 9:39am
tags:
Reality Check on the Big Pharma Rumor Mill
Seeking Alpha
Friday, October 31, 2008 - 9:39am
tags:
Sanofi Increases Forecast as Profit Beats Estimates
Bloomberg
Friday, October 31, 2008 - 9:23am
tags:
Analysts see Allergan shares as long-term bet
Yahoo/AP
Friday, October 31, 2008 - 9:20am
tags:
Geron’s Q3 loss grows to $17.2M
Bizjournals.com
Friday, October 31, 2008 - 9:13am
tags:
Endo Pharmaceuticals Holdings increases 2008 profit outlook, reaffirms revenue guidance
Yahoo/AP
Friday, October 31, 2008 - 9:11am
tags:
Daiichi Sankyo Cuts Profit Forecast on Ranbaxy, R&D
Bloomberg
Friday, October 31, 2008 - 9:04am
tags:
Therapy plus Zoloft helps kids with anxiety
Yahoo/AP
Friday, October 31, 2008 - 9:02am
tags:
What's on Deck for AstraZeneca?
Motley Fool
Friday, October 31, 2008 - 9:00am
tags:
A Big Upgrade for Pfizer
Motley Fool
Friday, October 31, 2008 - 8:59am
tags:
Biogen to Pay Genentech in Cancer-Drug Collaboration
Bloomberg
Friday, October 31, 2008 - 8:57am
tags:
ImClone's Erbitux to Get Quicker Review by U.S. FDA
Bloomberg
Friday, October 31, 2008 - 8:48am
tags:
AstraZeneca Chooses Acquisitions Over Buybacks, Joining Glaxo
Bloomberg
Thursday, October 30, 2008 - 12:08pm
tags:
Mylan Profit Jumps 15% on Sale of Blood-Pressure Drug
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:
Novo May Spend as Much as $2 Billion on Takeovers
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline
Metallic Flatland
In the Pipeline
The Continuing Crisis, Part XI: Feral Children, Breaking Things
In the Pipeline
Methyl Groups Will Always Be Magic
In the Pipeline
Predicting Picky Protein Interactions
In the Pipeline
The Continuing Crisis, Part X: Reductions in Force, Gains in Centralized Power
In the Pipeline
A New Pan-Coronovirus Protease Inhibitor Possibility
In the Pipeline
Pain Continues to Be a Pain
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.